Status and phase
Conditions
Treatments
About
This is a Phase Ib/II, open-label, multicenter, randomized, umbrella study in participants with locally advanced squamous cell carcinoma of the head and neck (SCCHN). The study will enroll treatment-naive participants with resectable Stage III-IVA human papillomavirus (HPV)-negative, programmed death-ligand 1 (PD-L1)-positive SCCHN with measurable disease, as assessed by the investigator according to Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1) who have not received systemic treatment for their disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Specific Exclusion Criteria for Atezo+Tira+CP:
Primary purpose
Allocation
Interventional model
Masking
12 participants in 2 patient groups
Loading...
Central trial contact
Reference Study ID Number: CO43613 https://forpatients.roche.com/
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal